Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old
- People who have been diagnosed with a stomach tumour called a GIST (a type of gastrointestinal stromal tumour), confirmed by a tissue sample taken during a scope procedure, or confirmed after surgery
- People who have provided written agreement to take part in the trial
- People whose tumour is expected to be fully removed by keyhole (laparoscopic) surgery, with no cancer left behind
- People who are generally well enough to carry out light activity, as measured by a standard health scale (ECOG score of 0 or 1)
- People considered to be at low to moderate risk for anaesthesia, as assessed by a standard medical rating (ASA class I to III)
- People whose tumour measures 10 centimetres or less at its widest point
Who may not be able to join:
- People who are pregnant or breastfeeding
- People who have a serious mental health condition
- People who have had previous surgery on the upper abdomen, except for keyhole gallbladder removal
- People who have had previous surgery on the stomach, including certain endoscopic procedures for stomach cancer
- People who do not wish to have keyhole surgery
- People who have had another cancer diagnosis within the past five years
- People who have had unstable chest pain (angina) or a heart attack in the past six months
- People who have had a stroke or related brain blood vessel event in the past six months
- People who have been taking corticosteroid medications regularly for at least one month leading up to the trial
- People who need another surgical procedure performed at the same time
- People who require emergency surgery due to serious complications such as bleeding, blockage, or a hole in the stomach
- People whose lung breathing capacity (FEV1) is below 50% of the normal expected level (confirm with trial site)
- People whose tumour measures more than 10 centimetres at its widest point
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3-year disease free survival rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.